AJO LP’s Lexicon Pharmaceuticals LXRX Stock Holding History

AJO LP’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-85,580	Closed	-$1.55M	–	543
2016 Q3	$1.55M	Sell	85,580 -975	-1%	-$15.7K	0.01%	361
2016 Q2	$1.24M	Buy	+86,555	New	+$1.17M	0.01%	378

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AJO LP's LXRX Position: Q4 2016 in Review

AJO LP sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2016, closing a stake of 85,580 shares — an estimated $1.55M sold.

AJO LP first reported a position in LXRX in Q2 2016 and held it in 2 quarters. The position peaked at $1.55M in Q3 2016. 146 funds tracked by Wall St. Rank hold LXRX as of Q4 2016.

AJO LP reported no remaining Lexicon Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
AJO LP sold 85,580 Lexicon Pharmaceuticals shares in Q4 2016, an estimated $1.55M.
AJO LP first reported a position in Lexicon Pharmaceuticals in Q2 2016 and held it in 2 quarters.
AJO LP's Lexicon Pharmaceuticals position peaked at $1.55M in Q3 2016.
146 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2016.

Based on AJO LP's 13F filing for Q4 2016, filed 14 Feb 2017.